| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.03. | Pulmatrix GAAP EPS of -$3.87, revenue of $7.3M | 1 | Seeking Alpha | ||
| 28.03. | Pulmatrix, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 28.03. | Pulmatrix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.03. | Pulmatrix Inc.: Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update | 116 | PR Newswire | 2023 year-end $19.2 million cash and cash equivalents provide projected cash runway into Q1 2026
3rd amendment to Cipla partnership resulted in the wind down of the PUR1900 Phase 2b study and a significant... ► Artikel lesen | |
| 13.03. | Pulmatrix CMO position eliminated, shifts to outsourced CMO model | 1 | Investing.com | ||
| 13.03. | Pulmatrix, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.03. | Pulmatrix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.01. | Pulmatrix To Stop PUR1900 Phase 2B Study Patient Enrollment And Closing The Study | 2 | RTTNews | ||
| 08.01. | Pulmatrix Inc.: Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives | 158 | PR Newswire | Cipla to take sole responsibility for development of PUR1900, refocused on markets with greatest unmet need and faster path to approval, in exchange for 2% royalty on net sales payable to Pulmatrix... ► Artikel lesen | |
| 08.01. | Pulmatrix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.11.23 | Pulmatrix Down on Q3 Results | 4 | Baystreet.ca | ||
| 09.11.23 | Pulmatrix GAAP EPS of -$1.03, revenue of $1.75M | 1 | Seeking Alpha | ||
| 09.11.23 | Pulmatrix, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 09.11.23 | Pulmatrix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.11.23 | Pulmatrix Inc.: Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update | 223 | PR Newswire | Patient enrollment for the Phase 2b study of PUR1900 is ongoing with four additional sites added during Q3, totaling seventeen active sites to date in four countries; topline data anticipated in H2... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 7.387 |
| TESLA | 3.655 |
| NVIDIA | 1.944 |
| TUI | 1.523 |
| NEL | 1.381 |
| SUPER MICRO COMPUTER | 1.302 |
| VARTA | 1.167 |
| META PLATFORMS | 1.107 |
| RHEINMETALL | 1.081 |
| BAYER | 1.075 |
| INFINEON | 1.052 |
| DEUTSCHE BANK | 1.029 |
| AIXTRON SE | 957 |
| RENK GROUP | 913 |
| BYD | 776 |
| PLUG POWER | 762 |
| BASF | 712 |
| COMMERZBANK | 646 |
| DEUTSCHE LUFTHANSA | 593 |
| RWE | 578 |
| THYSSENKRUPP | 528 |
| ALLIANZ | 513 |
| MERCEDES-BENZ | 500 |
| VOLKSWAGEN | 466 |
| DEUTSCHE TELEKOM | 445 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
